2. Signaling Pathways
  3. Immunology/Inflammation
  4. Interleukin Related
  5. IL-7 Isoform
  6. IL-7 Antagonist

IL-7 Antagonist

IL-7 Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P99412
    Lusvertikimab
    		Antagonist 99.41%
    Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research.